Sodium Oxybate 72865-0349-18
- Manufacturer
- Xlcare Pharmaceuticals, Inc.
- Dosage Form
- Solution
- Route
- Oral
- Product Type
- Human Prescription Drug
- DEA Schedule
- Schedule CIII
- Marketing Start
- January 1, 2026
- Listing Expires
- December 31, 2027
- Application
- ANDA210523
Active Ingredients
| Ingredient | Strength |
|---|---|
| Sodium Oxybate | .5 g/mL |
Drug Class
Central Nervous System Depressant [EPC]Central Nervous System Depression [PE]Decreased Central Nervous System Organized Electrical Activity [PE]
Selected Package
72865-0349-18Selected1 BOTTLE in 1 CARTON (72865-349-18) / 180 mL in 1 BOTTLE